157 related articles for article (PubMed ID: 32419347)
1. Response and outcome following radiation therapy of macroscopic canine plasma cell tumours.
Elliott J; Looper J; Keyerleber M; Turek M; Blackwood L; Henry J; Gieger T
Vet Comp Oncol; 2020 Dec; 18(4):718-726. PubMed ID: 32419347
[TBL] [Abstract][Full Text] [Related]
2. Definitive-intent intensity-modulated radiation therapy for treatment of canine prostatic carcinoma: A multi-institutional retrospective study.
Walz JZ; Desai N; Van Asselt N; Poirier VJ; Hansen K; Selmic L
Vet Comp Oncol; 2020 Sep; 18(3):381-388. PubMed ID: 31811693
[TBL] [Abstract][Full Text] [Related]
3. Survival data for canine oral extramedullary plasmacytomas: a retrospective analysis (1996-2006).
Wright ZM; Rogers KS; Mansell J
J Am Anim Hosp Assoc; 2008; 44(2):75-81. PubMed ID: 18316443
[TBL] [Abstract][Full Text] [Related]
4. Dose-escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs.
Meier V; Staudinger C; Körner M; Soukup A; Rohrer Bley C
Vet Radiol Ultrasound; 2022 Sep; 63(5):633-648. PubMed ID: 35347801
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.
Kilciksiz S; Celik OK; Pak Y; Demiral AN; Pehlivan M; Orhan O; Tokatli F; Agaoglu F; Zincircioglu B; Atasoy BM; Ozseker N; Yersal O; Niang U; Haydaroglu A;
Am J Hematol; 2008 Sep; 83(9):702-7. PubMed ID: 18543343
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma.
Lee BI; LaRue SM; Seguin B; Griffin L; Prebble A; Martin T; Leary D; Boss MK
Vet Comp Oncol; 2020 Dec; 18(4):843-853. PubMed ID: 32515526
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiation therapy for canine multilobular osteochondrosarcoma: Eight cases.
Sweet KA; Nolan MW; Yoshikawa H; Gieger TL
Vet Comp Oncol; 2020 Mar; 18(1):76-83. PubMed ID: 30989784
[TBL] [Abstract][Full Text] [Related]
8. Treatment of canine oral papillary squamous cell carcinoma using definitive-intent radiation as a monotherapy-a case series.
van der Steen F; Zandvliet M
Vet Comp Oncol; 2021 Mar; 19(1):152-159. PubMed ID: 32975025
[TBL] [Abstract][Full Text] [Related]
9. Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcoma.
Nolan MW; Green NA; DiVito EM; Lascelles BDX; Haney SM
Vet Comp Oncol; 2020 Dec; 18(4):538-547. PubMed ID: 32048435
[TBL] [Abstract][Full Text] [Related]
10. Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma.
Oertel M; Elsayad K; Kroeger KJ; Haverkamp U; Rudack C; Lenz G; Eich HT
Radiat Oncol; 2019 Apr; 14(1):63. PubMed ID: 30987659
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
12. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
13. Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases.
Venkatesulu B; Mallick S; Giridhar P; Upadhyay AD; Rath GK
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):595-606. PubMed ID: 29224044
[TBL] [Abstract][Full Text] [Related]
14. Short survival time following palliative-intent hypofractionated radiotherapy for non-resectable canine thyroid carcinoma: A retrospective analysis of 20 dogs.
Tsimbas K; Turek M; Christensen N; Vail DM; Forrest L
Vet Radiol Ultrasound; 2019 Jan; 60(1):93-99. PubMed ID: 30180282
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy for incompletely resected canine mast cell tumors.
LaDue T; Price GS; Dodge R; Page RL; Thrall DE
Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
[TBL] [Abstract][Full Text] [Related]
16. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
[TBL] [Abstract][Full Text] [Related]
17. Proton spot scanning radiotherapy of spontaneous canine tumors.
Mayer-Stankeová S; Fidel J; Wergin MC; Hauser B; Sumová A; Goitein G; Pedroni E; Lomax AJ; Schneider U; Blattmann H; Kaser-Hotz B
Vet Radiol Ultrasound; 2009; 50(3):314-8. PubMed ID: 19507399
[TBL] [Abstract][Full Text] [Related]
18. Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017).
Stevens A; Turek M; Vail D; Christensen N; Forrest L
Vet Radiol Ultrasound; 2020 Nov; 61(6):718-725. PubMed ID: 32713101
[TBL] [Abstract][Full Text] [Related]
19. Solitary osseous plasmacytomas in dogs: 13 cases (2004-2019).
Reising AJ; Donnelly LL; Flesner BK; Maitz CA; Bryan JN
J Small Anim Pract; 2021 Dec; 62(12):1114-1121. PubMed ID: 34467522
[TBL] [Abstract][Full Text] [Related]
20. Description and efficacy of a response-based "QUAD" cyclical hypofractionated palliative-intent radiation protocol in dogs with macroscopic solid tumours: 108 cases.
Sylvester SR; Henry JG; Basran PS; McEntee MC
Vet Comp Oncol; 2023 Sep; 21(3):378-390. PubMed ID: 37068761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
